Physician profile
Qi Zhang
NPI 1720220734
$3,677.77
in general payments reported to CMS, 2019-2025
18 companies · $392 in 2025
The $392 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $277 · 2021: $644 · 2022: $761 · 2023: $850 · 2024: $443 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,685.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $825.77 | 2022-2025 | Proclaim, Eterna |
| Collegium Pharmaceutical, INC. | $761.53 | 2019-2025 | Xtampza, Belbuca |
| Nevro Corp. | $644.14 | 2019-2023 | Senza |
| Boston Scientific Corporation | $333.84 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $235.32 | 2020-2025 | Relistor |
| Vertos Medical, INC. | $212.00 | 2021-2023 | Mild Device Kit |
| Pfizer INC. | $128.45 | 2019-2021 | |
| Abbvie INC. | $120.71 | 2022-2024 | Botox, Ubrelvy |
| Daiichi Sankyo INC. | $90.10 | 2019 | |
| Allergan, INC. | $57.25 | 2019-2022 | |
| Spr Therapeutics, INC | $55.49 | 2025 | Sprint Pns System |
| Avanos Medical | $53.44 | 2019-2025 | |
| Medtronic, INC. | $40.79 | 2024 | Intellis Adaptivestim |
| Biohaven Pharmaceuticals, INC. | $33.67 | 2021 | |
| Biodelivery Sciences International, INC. | $30.19 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $28.72 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $14.65 | 2022 | |
| Redhill Biopharma INC. | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qi Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.